SBC Medical Group Holdings Incorporated Interest Expense
SBC Medical Group Holdings Incorporated (SBC) reported Interest Expense of $126.11 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated interest expense for the quarter ending 2026-06-30 was $126.11K, a 170.19% increase year-over-year.
- SBC Medical Group Holdings Incorporated interest expense for the quarter ending 2026-03-31 was $111.86K, a 2724.03% increase year-over-year.
- SBC Medical Group Holdings Incorporated interest expense for the quarter ending 2025-12-31 was $52.75K, a 325.35% increase year-over-year.
- SBC Medical Group Holdings Incorporated interest expense for the quarter ending 2025-09-30 was $44.85K, a 720.55% increase year-over-year.
- SBC Medical Group Holdings Incorporated interest expense for fiscal 2025 was $148.24K, a 423.81% increase from fiscal 2024.
- SBC Medical Group Holdings Incorporated interest expense for fiscal 2024 was $28.30K, a 37.52% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated interest expense for fiscal 2023 was $45.29K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $126.11K 10-Q · filed 2026-08-13 | $237.97K 10-Q · filed 2026-08-13 | $290.72K derived: sum of 3 quarters · filed 2026-08-13 | $335.57K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $111.86K 10-Q · filed 2026-05-14 | $164.61K derived: sum of 2 quarters · filed 2026-05-14 | $209.46K derived: sum of 3 quarters · filed 2026-05-14 | $256.14K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $52.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $97.60K derived: sum of 2 quarters · filed 2026-03-27 | $144.28K derived: sum of 3 quarters · filed 2026-08-13 | $148.24K 10-K · filed 2026-03-27 |
| 2025-09-30 | $44.85K 10-Q · filed 2025-11-14 | $91.53K derived: sum of 2 quarters · filed 2026-08-13 | $95.49K 10-Q · filed 2025-11-14 | $107.89K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $46.67K 10-Q · filed 2026-08-13 | $50.63K 10-Q · filed 2026-08-13 | $63.04K derived: sum of 3 quarters · filed 2026-08-13 | $68.50K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.96K 10-Q · filed 2026-05-14 | $16.36K derived: sum of 2 quarters · filed 2026-05-14 | $21.83K derived: sum of 3 quarters · filed 2026-05-14 | $29.25K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $12.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $17.87K derived: sum of 2 quarters · filed 2026-03-27 | $25.29K derived: sum of 3 quarters · filed 2026-03-27 | $28.30K 10-K · filed 2026-03-27 |
| 2024-09-30 | $5.47K 10-Q · filed 2025-11-14 | $12.89K derived: sum of 2 quarters · filed 2025-11-14 | $15.90K 10-Q · filed 2025-11-14 | $23.81K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $7.42K 10-Q · filed 2025-08-13 | $10.43K 10-Q · filed 2025-08-13 | $18.34K derived: sum of 3 quarters · filed 2025-08-13 | $22.32K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $3.01K 10-Q · filed 2025-05-15 | $10.92K derived: sum of 2 quarters · filed 2025-05-15 | $14.90K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $7.91K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $11.89K derived: sum of 2 quarters · filed 2025-03-28 | $45.29K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $3.98K 10-Q · filed 2024-11-13 | $37.38K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |